Wuhan Keqian Biology Co.,Ltd

SHSE:688526 Stock Report

Market Cap: CN¥6.4b

Wuhan Keqian BiologyLtd Balance Sheet Health

Financial Health criteria checks 5/6

Wuhan Keqian BiologyLtd has a total shareholder equity of CN¥3.9B and total debt of CN¥58.3M, which brings its debt-to-equity ratio to 1.5%. Its total assets and total liabilities are CN¥4.4B and CN¥573.3M respectively. Wuhan Keqian BiologyLtd's EBIT is CN¥234.7M making its interest coverage ratio -2.9. It has cash and short-term investments of CN¥1.1B.

Key information

1.5%

Debt to equity ratio

CN¥58.28m

Debt

Interest coverage ratio-2.9x
CashCN¥1.07b
EquityCN¥3.86b
Total liabilitiesCN¥573.29m
Total assetsCN¥4.43b

Recent financial health updates

Recent updates

The Market Lifts Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Shares 38% But It Can Do More

Oct 09
The Market Lifts Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Shares 38% But It Can Do More

These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well

Sep 26
These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well

Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)

Aug 20
Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)

We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Jun 26
We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt

Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Apr 08
Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company

Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Apr 05
Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be

Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Apr 03
Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts

Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Mar 20
Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet

Financial Position Analysis

Short Term Liabilities: 688526's short term assets (CN¥2.4B) exceed its short term liabilities (CN¥485.3M).

Long Term Liabilities: 688526's short term assets (CN¥2.4B) exceed its long term liabilities (CN¥88.0M).


Debt to Equity History and Analysis

Debt Level: 688526 has more cash than its total debt.

Reducing Debt: 688526's debt to equity ratio has increased from 0% to 1.5% over the past 5 years.

Debt Coverage: 688526's debt is well covered by operating cash flow (627.1%).

Interest Coverage: 688526 earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies